MedPath

Investigating the long-term impact of nicotine replacement products on tobacco smoking cessation for low-socioeconomic status smokers

Not Applicable
Recruiting
Conditions
Public Health - Health service research
Mental Health - Addiction
Tobacco smoking
Registration Number
ACTRN12622001147774
Lead Sponsor
niversity of New South Wales
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
160
Inclusion Criteria

Participants can be included if they meet the primary outcome of six-month continuous abstinence in ACTRN12621000076875 (defined as self-report of having smoked less than or equal to 5 cigarettes in that time and carbon monoxide level of less than or equal to 5ppm using biochemical breath test verification) and provide informed consent.

Exclusion Criteria

There are no exclusion criteria.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Carbon monoxide (CO) verified 18-month continuous abstinence at 19-month follow-up. Continuous 18-month abstinence will be defined as having remained quit for 18-months (having smoked no more than five cigarettes in that time), and a carbon monoxide level of less-than-or-equal-to 5 parts per million. Depending on the participants indicated preference, the CO breath test will be self-administered using an using a hand-held iCO™ Smokerlyzer® (using provided instructions), or administered by a trained researcher using a hand-held iCO™ Micro+™ Smokerlyzer® with a disposable, one-use mouthpiece. [The follow-up interview will occur 19-months after the participant's baseline interview completion date for ACTRN12621000076875.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath